DK1083885T3 - Delavirdintabletformulering - Google Patents

Delavirdintabletformulering

Info

Publication number: DK1083885T3
Authority: DK; Denmark
Prior art keywords: delavirdine; tablet formulation; amount; superdisintegrant; binder
Prior art date: 1998-06-11

Application number

DK99925951T

Other languages

Danish (da)

English (en)

Inventor

Walter Morozowich

Alice C Martino

Ashley H Bates

E John Lee

Original Assignee

Pharmacia & Upjohn Co Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-11

Filing date

1999-06-07

Publication date

2007-02-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22214517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1083885(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-06-07 Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc

2007-02-26 Application granted granted Critical

2007-02-26 Publication of DK1083885T3 publication Critical patent/DK1083885T3/da

Links

239000007916 tablet composition Substances 0.000 title abstract 2
WHBIGIKBNXZKFE-UHFFFAOYSA-N delavirdine Chemical compound CC(C)NC1=CC=CN=C1N1CCN(C(=O)C=2NC3=CC=C(NS(C)(=O)=O)C=C3C=2)CC1 WHBIGIKBNXZKFE-UHFFFAOYSA-N 0.000 title 2
229960005319 delavirdine Drugs 0.000 title 1
239000011230 binding agent Substances 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
230000001376 precipitating effect Effects 0.000 abstract 2
238000010438 heat treatment Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cephalosporin Compounds (AREA)

DK99925951T 1998-06-11 1999-06-07 Delavirdintabletformulering DK1083885T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8896098P	1998-06-11	1998-06-11
PCT/US1999/011798 WO1999063970A1 (en)	1998-06-11	1999-06-07	Delavirdine tablet formulation

Publications (1)

Publication Number	Publication Date
DK1083885T3 true DK1083885T3 (da)	2007-02-26

Family

ID=22214517

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99925951T DK1083885T3 (da)	1998-06-11	1999-06-07	Delavirdintabletformulering

Country Status (20)

Country	Link
US (3)	US6177101B1 (de)
EP (1)	EP1083885B1 (de)
JP (1)	JP4827296B2 (de)
KR (2)	KR100724016B1 (de)
CN (1)	CN1237958C (de)
AT (1)	ATE349203T1 (de)
AU (1)	AU753241C (de)
BR (1)	BR9910481A (de)
CA (1)	CA2328703C (de)
CY (1)	CY1105924T1 (de)
DE (1)	DE69934582T2 (de)
DK (1)	DK1083885T3 (de)
EA (1)	EA004311B1 (de)
ES (1)	ES2277682T3 (de)
HU (1)	HUP0102206A3 (de)
NZ (1)	NZ508762A (de)
PL (1)	PL200163B1 (de)
PT (1)	PT1083885E (de)
WO (1)	WO1999063970A1 (de)
ZA (1)	ZA200006090B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1083885T3 (da) *	1998-06-11	2007-02-26	Pharmacia & Upjohn Co Llc	Delavirdintabletformulering
GEP20053427B (en)	1999-12-23	2005-01-25	Pfizer Prod Inc	Pharmaceutical Compositions Providing Enhanced Drug Concentrations
US7115279B2 (en)	2000-08-03	2006-10-03	Curatolo William J	Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20040243118A1 (en) *	2001-06-01	2004-12-02	Ayers Gregory M.	Device and method for positioning a catheter tip for creating a cryogenic lesion
DE60204897T2 (de) *	2001-08-28	2006-05-11	Pharmacia Corp.	Kristalline freie base von clindamycin
DE10164510A1 (de)	2001-12-20	2003-07-10	Schering Ag	Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
JP2004107258A (ja) *	2002-09-18	2004-04-08	Ss Pharmaceut Co Ltd	催眠用圧縮成型製剤
WO2004066981A1 (en) *	2003-01-29	2004-08-12	Sun Pharmaceutical Industries Limited	Oral controlled release pharmaceutical composition containing metaxalone as active agent
EP1613333A1 (de) *	2003-04-04	2006-01-11	Pharmacia Corporation	Orale gepresste multipartikuläre tabletten mit verlängerter freisetzung
ES2752773T3 (es)	2003-06-13	2020-04-06	Idh Holding Aps	Tratamiento de los síntomas asociados a la vaginosis bacteriana
CA2531116A1 (en) *	2003-07-01	2005-01-20	Michael Hawley	Diffusion layer modulated solids
US7201920B2 (en)	2003-11-26	2007-04-10	Acura Pharmaceuticals, Inc.	Methods and compositions for deterring abuse of opioid containing dosage forms
US20050283146A1 (en) *	2004-06-17	2005-12-22	Lentz David J	Thermally extended spiral cryotip for a cryoablation catheter
US20060099253A1 (en) *	2004-10-20	2006-05-11	Wyeth	Antibiotic product formulation
US20070059359A1 (en) *	2005-06-07	2007-03-15	Thomas Backensfeld	Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
EP2048394B1 (de)	2006-07-27	2014-05-07	Kabushiki Kaisha Kobe Seiko Sho	Kneteinrichtung mit knetvorrichtung und antriebsvorrichtung, die durch die verbindungsvorrichtung miteinander verbunden sind
CA2617688C (en) *	2007-02-22	2015-08-18	Alpex Pharma S.A.	Solid dosage formulations containing weight-loss drugs
US8696606B2 (en) *	2009-09-28	2014-04-15	Continuous MotionFlow, LLC	Passive motion machine with integrated mechanical DVT prophylactic therapy
EP3064064A1 (de)	2009-09-30	2016-09-07	Acura Pharmaceuticals, Inc.	Verfahren und zusammensetzungen zur abschreckung vor missbrauch
JP5226732B2 (ja) *	2010-05-20	2013-07-03	エスエス製薬株式会社	催眠用圧縮成型製剤
US20120010216A1 (en) *	2010-07-06	2012-01-12	Brown Arthur M	Pharmaceutical compositions containing vanoxerine
US10201584B1 (en)	2011-05-17	2019-02-12	Abbvie Inc.	Compositions and methods for treating HCV
EA032913B1 (ru)	2012-10-18	2019-08-30	Эббви Инк.	Препараты производных пиримидиндиона
MX366159B (es)	2012-11-30	2019-07-01	Acura Pharmaceuticals Inc	Liberacion autorregulada de ingrediente farmaceutico activo.
SG10201910773VA (en)	2013-06-13	2020-01-30	Akebia Therapeutics Inc	Compositions and methods for treating anemia
EP3089757A1 (de)	2014-01-03	2016-11-09	AbbVie Inc.	Feste antivirale darreichungsformen
WO2017040607A1 (en)	2015-08-31	2017-03-09	Acura Pharmaceuticals, Inc.	Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA2937365C (en)	2016-03-29	2018-09-18	F. Hoffmann-La Roche Ag	Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
KR102942294B1 (ko) *	2018-05-15	2026-03-23	장쑤 한서 파마슈티칼 그룹 캄파니 리미티드	소분자 이지에프알 억제제를 포함하는 약학 조성물 및 그의 제조 방법
CN108619104A (zh) *	2018-06-29	2018-10-09	哈尔滨珍宝制药有限公司	一种基于盐酸克林霉素的药物组合物及其制备方法
CZ309820B6 (cs) *	2021-04-23	2023-11-08	Pro.Med.Cs Praha A.S.	Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4013785A (en) *	1975-03-21	1977-03-22	Bristol-Myers Company	Apap tablet containing fumed silica and process for manufacturing same
ZA855250B (en) *	1984-08-17	1986-02-26	Upjohn Co	Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8521350D0 (en) *	1985-08-28	1985-10-02	Euro Celtique Sa	Analgesic composition
DE3708916A1 (de)	1987-03-19	1988-09-29	Boehringer Ingelheim Kg	Verfahren zur reinigung resorbierbarer polyester
EP0319074B1 (de) *	1987-11-30	1992-01-29	Brocades Pharma B.V.	Pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung
US5211958A (en) *	1987-11-30	1993-05-18	Gist-Brocades, N.V.	Pharmaceutical composition and process for its preparation
GB8824392D0 (en) *	1988-10-18	1988-11-23	Ciba Geigy Ag	Dispersible formulation
US5256699A (en) *	1988-10-18	1993-10-26	Ciba-Geify Corporation	Dispersible tablet formulation of diclofenac acid free base
CA2007764C (en)	1989-02-24	1999-11-30	Joseph Michael Beaurline	Salsalate tablet
GB8909793D0 (en) *	1989-04-28	1989-06-14	Beecham Group Plc	Pharmaceutical formulation
CA2031803C (en)	1989-12-13	2001-05-29	Ramakrishnan Nagarajan	Improvements in or relating to glycopeptide deriveratives
US5563142A (en) *	1989-12-28	1996-10-08	The Upjohn Company	Diaromatic substituted compounds as anti-HIV-1 agents
US5665720A (en) *	1992-08-07	1997-09-09	Merck & Co., Inc.	Benzoxazinones as inhibitors of HIV reverse transcriptase
US5358941A (en)	1992-12-02	1994-10-25	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids with lactose
FR2711524B1 (fr) *	1993-10-21	1995-11-24	Rhone Dpc Europ	Procédé de préparation de compositions orales contenant des quinolones.
SK282424B6 (sk)	1994-04-15	2002-01-07	Pharmacia + Upjohn Company	"S" a "T" kryštalické formy 1-[5-metánsulfónamidoindolyl-2- karbonyl]-4-[3-(1-metyl-etylamino)-2-pyridinyl] piperazínu
US5585115A (en) *	1995-01-09	1996-12-17	Edward H. Mendell Co., Inc.	Pharmaceutical excipient having improved compressability
US5837292A (en)	1996-07-03	1998-11-17	Yamanouchi Europe B.V.	Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
US6013280A (en) *	1997-10-07	2000-01-11	Fuisz Technologies Ltd.	Immediate release dosage forms containing microspheres
US5955107A (en) *	1997-12-12	1999-09-21	Fmc Corporation	Pharmaceutical suspension tablet compositions
UA72207C2 (uk) *	1998-04-07	2005-02-15	Брістол- Майєрс Сквібб Фарма Компані	Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
DK1083885T3 (da) *	1998-06-11	2007-02-26	Pharmacia & Upjohn Co Llc	Delavirdintabletformulering

1999
- 1999-06-07 DK DK99925951T patent/DK1083885T3/da active
- 1999-06-07 BR BR9910481-4A patent/BR9910481A/pt not_active Application Discontinuation
- 1999-06-07 HU HU0102206A patent/HUP0102206A3/hu unknown
- 1999-06-07 JP JP2000553039A patent/JP4827296B2/ja not_active Expired - Lifetime
- 1999-06-07 WO PCT/US1999/011798 patent/WO1999063970A1/en not_active Ceased
- 1999-06-07 EP EP99925951A patent/EP1083885B1/de not_active Revoked
- 1999-06-07 PL PL344328A patent/PL200163B1/pl unknown
- 1999-06-07 AT AT99925951T patent/ATE349203T1/de active
- 1999-06-07 AU AU42134/99A patent/AU753241C/en not_active Expired
- 1999-06-07 NZ NZ508762A patent/NZ508762A/en not_active IP Right Cessation
- 1999-06-07 PT PT99925951T patent/PT1083885E/pt unknown
- 1999-06-07 EA EA200100024A patent/EA004311B1/ru not_active IP Right Cessation
- 1999-06-07 DE DE69934582T patent/DE69934582T2/de not_active Revoked
- 1999-06-07 KR KR1020007013985A patent/KR100724016B1/ko not_active Expired - Lifetime
- 1999-06-07 CA CA002328703A patent/CA2328703C/en not_active Expired - Lifetime
- 1999-06-07 KR KR1020077007572A patent/KR20070040426A/ko not_active Ceased
- 1999-06-07 US US09/327,135 patent/US6177101B1/en not_active Expired - Lifetime
- 1999-06-07 ES ES99925951T patent/ES2277682T3/es not_active Expired - Lifetime
- 1999-06-07 CN CNB998062316A patent/CN1237958C/zh not_active Expired - Lifetime
2000
- 2000-09-06 US US09/656,364 patent/US7108864B1/en not_active Expired - Lifetime
- 2000-10-27 ZA ZA200006090A patent/ZA200006090B/xx unknown
2006
- 2006-07-14 US US11/487,554 patent/US20060257476A1/en not_active Abandoned
2007
- 2007-01-15 CY CY20071100050T patent/CY1105924T1/el unknown

Also Published As

Publication number	Publication date
CN1301149A (zh)	2001-06-27
HUP0102206A2 (hu)	2002-03-28
PL200163B1 (pl)	2008-12-31
PL344328A1 (en)	2001-10-22
DE69934582T2 (de)	2007-10-04
HUP0102206A3 (en)	2002-12-28
US7108864B1 (en)	2006-09-19
CA2328703C (en)	2007-10-30
CA2328703A1 (en)	1999-12-16
EP1083885A1 (de)	2001-03-21
ATE349203T1 (de)	2007-01-15
EA004311B1 (ru)	2004-02-26
KR20070040426A (ko)	2007-04-16
EP1083885B1 (de)	2006-12-27
JP4827296B2 (ja)	2011-11-30
AU4213499A (en)	1999-12-30
WO1999063970A1 (en)	1999-12-16
HK1036417A1 (en)	2002-01-04
KR100724016B1 (ko)	2007-05-31
EA200100024A1 (ru)	2001-06-25
CY1105924T1 (el)	2011-04-06
ZA200006090B (en)	2001-10-29
US6177101B1 (en)	2001-01-23
DE69934582D1 (de)	2007-02-08
NZ508762A (en)	2003-07-25
US20060257476A1 (en)	2006-11-16
JP2002517430A (ja)	2002-06-18
KR20010052717A (ko)	2001-06-25
BR9910481A (pt)	2001-01-09
AU753241C (en)	2003-05-08
ES2277682T3 (es)	2007-07-16
AU753241B2 (en)	2002-10-10
CN1237958C (zh)	2006-01-25
PT1083885E (pt)	2007-01-31

Publication	Publication Date	Title
DK1083885T3 (da)	2007-02-26	Delavirdintabletformulering
GEP20053420B (en)	2005-01-25	Sustained Release Ranolanolazine Formulation
BG105568A (en)	2002-01-31	Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
AU3080895A (en)	1996-02-16	Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
KR930016091A (ko)	1993-08-26	거의 수불용성인 약제의 고체 분산액을 제조하는 방법
DK0730444T3 (da)	2003-04-14	Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.
GB2186485B (en)	1988-09-07	Slow release formulation
NO934573L (no)	1993-12-13	Farmasoeytiske formuleringer av oste-orgeniske proteiner
EP2266542A3 (de)	2013-07-31	Nanopartikelformulierungen mit kontrollierter Wirkstofffreisetzung
BR9808933A (pt)	2000-08-01	Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
ATE145132T1 (de)	1996-11-15	Therapeutische zusammensetzung und verfahren für ihre herstellung
FR2744449B1 (fr)	1998-04-24	Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
TR199901433T2 (xx)	1999-09-21	Pirolo$3,4-D] pirimidinon t�revleri ve bunlar�n ila� olarak kullan�mlar�.
AU6404398A (en)	1998-10-20	New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
GEP20033062B (en)	2003-09-25	Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
DE69632194D1 (de)	2004-05-19	Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
HUP0001093A3 (en)	2001-07-30	Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
TR200003303T2 (tr)	2001-01-22	Astıma, alerjiye, iltihaplanmaya karşı, bağışıklık düzenleyici ve sinirsel koruyucu etkiye sahip yeni 1,5- ve 3-O-ikameli 1H-indazoller, bunların hazırlanması ve tıbbi maddeler olarak kullanımları.
MY120550A (en)	2005-11-30	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
IL127518A (en)	2003-05-29	Substituted heterocyclic benzocycloalkenes, their preparation and pharmaceutical compositions having an analgesic effect
AU5139596A (en)	1996-10-08	Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
MD970269A (en)	1999-05-31	Clavulanates
GEP20012518B (en)	2001-08-27	Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
AU1606997A (en)	1997-08-22	Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs
TR199900013T2 (xx)	1999-04-21	Yeni bile�ikler.